NCT00019838View on ClinicalTrials.gov

UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Conditions
LeukemiaLymphoma
Interventions
DRUG

7-hydroxystaurosporine

DRUG

fludarabine phosphate

Trial Locations (2)

20892

NCI - Center for Cancer Research, Bethesda

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00019838 - UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia | Biotech Hunter | Biotech Hunter